Menu
Back to User profile » Dr Reham Abdel-Wahab
Papers published by Dr Reham Abdel-Wahab:
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
Ali MA, Lacin S, Abdel-Wahab R, Uemura M, Hassan M, Rashid A, Duda DG, Kaseb AO
OncoTargets and Therapy 2017, 10:1403-1412
Published Date: 3 March 2017
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
Kaseb AO, Morris JS, Iwasaki M, Al-Shamsi HO, Raghav KP, Girard L, Cheung S, Nguyen V, Elsayes KM, Xiao L, Abdel-Wahab R, Shalaby AS, Hassan M, Hassabo HM, Wolff RA, Yao JC
OncoTargets and Therapy 2016, 9:773-780
Published Date: 15 February 2016
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO
Journal of Hepatocellular Carcinoma 2016, 3:1-7
Published Date: 5 February 2016
Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma
Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO
Journal of Hepatocellular Carcinoma 2015, 2:131-142
Published Date: 18 September 2015